Covid-19 Top Updates: India records 18,840 fresh infections, 43 deaths

Covid-19 Top Updates: India records 18,840 fresh infections, 43 deaths

India witnessed 18,840 new coronavirus cases in the country in the last 24 hours, the data released by the union health ministry suggests. The death toll has risen to 5,25,386 with 43 new Covid-related deaths in the last 24 hours. As of now, there are over 1,25,028 active coronavirus cases in the country. The daily … Read more

NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years

NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years

The NTAGI’s Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. However, there was no decision on introducing these vaccines in the vaccination programme. Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five … Read more

NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap

NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The National Technical Advisory Group on Immunisation (NTAGI) will hold its meeting amid a … Read more

NTAGI to discuss allowing Corbevax as booster for those vaccinated with Covishield, Covaxin: Sources

NTAGI to discuss allowing Corbevax as booster for those vaccinated with Covishield, Covaxin: Sources

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the vaccines to six months are among the issues likely to be discussed at a meeting of the NTAGI to be held soon. The … Read more

Corbevax gets nod from DGCI as heterologous Covid-19 booster

Corbevax gets nod from DGCI as heterologous Covid-19 booster

Biological E’s corbevax has become the first vaccine in India to get regulatory approval for a heterologous Covid-19 booster shot. People who are 18 years and above and have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous Covid-19 booster. Hyderabad-based pharmaceutical and vaccines company … Read more

Biological E reduces Corbevax Covid-19 vaccine price to Rs 250 per dose

Biological E reduces Corbevax Covid-19 vaccine price to Rs 250 per dose

Biological E, a Hyderabad-based vaccine maker, on Monday announced a reduction in the price of the Corbevax Covid-19 vaccine to Rs 250 a dose. Corbevax was earlier priced at Rs 840 per dose. The new price of Rs 250 per dose, inclusive of GST, will be charged for the vaccine at private Covid-19 vaccination centres. … Read more

Corbevax & Covaxin Covid-19 vaccines get nod for kids below 12 years

Corbevax & Covaxin Covid-19 vaccines get nod for kids below 12 years

The Drugs Controller General of India (DCGI) granted emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children aged five to 12 years, and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, on Tuesday. The DCGI has also granted emergency use authorisation (EUA) to Cadila for its ZyCoV-D … Read more

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

DCGI Approved Corbevax Vaccine for 5 to 12 Years Age Group, Covaxin Vaccine for 6-12 Age Groups: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) to Covaxin for use in 6 to 12 years old children. The national drug regulator has asked Covaxin manufacturer Bharat Biotech to submit safety data. … Read more

Over 3 lakh doses of Covid vaccine given to children aged 12-14 years on day 1

Over 3 lakh doses of Covid vaccine given to children aged 12-14 years on day 1

The vaccination against COVID-19 in the age group of 12-14 years started on Wednesday with Biological E’s intramuscular vaccine Corbevax, two doses of which are to be administered 28 days apart. Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the … Read more

Covid-19 vaccine update: Biological E’s Corbevax to cost Rs 800 per dose

Covid-19 vaccine update: Biological E’s Corbevax to cost Rs 800 per dose

Datla claimed the Corbevax vaccine was superior to the Covishield vaccine and could neutralise multiple variants of concern including Beta, Delta and the most recent Omicron variant. She said it has persistent immunity, which lasts longer with a minimal drop in antibody titers. Biological E has priced its Corbevax vaccine, meant for children in the … Read more